MiR-101-3p Suppresses Progression of Cervical Squamous Cell Carcinoma by Targeting and Down-Regulating KPNA2
暂无分享,去创建一个
[1] Z. Dai,et al. MicroRNA-139 inhibits hepatocellular carcinoma cell growth through down-regulating karyopherin alpha 2 , 2019, Journal of Experimental & Clinical Cancer Research.
[2] Yumei Wu,et al. Use of mesothelin as a tumor-associated antigen in cervical squamous cell carcinoma. , 2019, Gene.
[3] Xiaotian Zhang,et al. Autotaxin is a novel target of microRNA‐101‐3p , 2019, FEBS open bio.
[4] Yushui Ma,et al. Prognostic implications of decreased microRNA-101-3p expression in patients with non-small cell lung cancer , 2018, Oncology letters.
[5] A. Jemal,et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.
[6] H. Shan,et al. LncRNA PTAR promotes EMT and invasion-metastasis in serous ovarian cancer by competitively binding miR-101-3p to regulate ZEB1 expression , 2018, Molecular Cancer.
[7] Shulin Chen,et al. Prognostic value of C-reactive protein/albumin ratio in predicting overall survival of Chinese cervical cancer patients overall survival: comparison among various inflammation based factors , 2018, Journal of Cancer.
[8] Jong Min Lee,et al. Comparison between adjuvant chemotherapy and adjuvant radiotherapy/chemoradiotherapy after radical surgery in patients with cervical cancer: a meta-analysis , 2018, Journal of gynecologic oncology.
[9] Xiao-yu Wu,et al. miR-101-3p Suppresses HOX Transcript Antisense RNA (HOTAIR)-Induced Proliferation and Invasion Through Directly Targeting SRF in Gastric Carcinoma Cells. , 2017, Oncology research.
[10] Xing Li,et al. mir-101-3p is a key regulator of tumor metabolism in triple negative breast cancer targeting AMPK , 2016, Oncotarget.
[11] Hsiang-Cheng Chi,et al. MicroRNA-26b inhibits tumor metastasis by targeting the KPNA2/c-jun pathway in human gastric cancer , 2016, Oncotarget.
[12] V. Rani,et al. Exploring miRNA based approaches in cancer diagnostics and therapeutics. , 2016, Critical reviews in oncology/hematology.
[13] J. Yun,et al. MiR-26b/KPNA2 axis inhibits epithelial ovarian carcinoma proliferation and metastasis through downregulating OCT4 , 2015, Oncotarget.
[14] J. Yun,et al. KPNA2 promotes cell proliferation and tumorigenicity in epithelial ovarian carcinoma through upregulation of c-Myc and downregulation of FOXO3a , 2013, Cell Death and Disease.
[15] E. Dahl,et al. Nuclear transport receptor karyopherin-α2 promotes malignant breast cancer phenotypes in vitro , 2012, Oncogene.
[16] Yu-Sun Chang,et al. Importin subunit alpha‐2 is identified as a potential biomarker for non‐small cell lung cancer by integration of the cancer cell secretome and tissue transcriptome , 2011, International journal of cancer.
[17] S. Arii,et al. Importin-α1 as a Novel Prognostic Target for Hepatocellular Carcinoma , 2011, Annals of Surgical Oncology.
[18] G. Kristiansen,et al. KPNA2 Expression Is an Independent Adverse Predictor of Biochemical Recurrence after Radical Prostatectomy , 2011, Clinical Cancer Research.
[19] Christian Pilarsky,et al. Molecular Profiling of Laser-Microdissected Matched Tumor and Normal Breast Tissue Identifies Karyopherin α2 as a Potential Novel Prognostic Marker in Breast Cancer , 2006, Clinical Cancer Research.
[20] Kou-Juey Wu,et al. Importin KPNA2 Is Required for Proper Nuclear Localization and Multiple Functions of NBS1* , 2005, Journal of Biological Chemistry.